Smoking rates declined globally for the first time on record, according to a new report on tobacco use. However, the figures from the Tobacco Atlas report also mask growing numbers of smokers in parts of the world, as well as increased tobacco use among young teenagers in almost half of the countries surveyed.
The Prescriber in 2022: Engaging HCPs in the COVID-Endemic EraBrands, Consumers, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Disease 2019 (COVID-19), Drug Delivery, Endemic, Europe, HCPs, Medical Devices, Mobile, Pharma, Physicians, Prescribers, Reports, Research, Telehealth, United States
Of all the communities touched by the COVID-19 pandemic, healthcare professionals (HCPs) are arguably among those most affected. Specialists on the front lines in primary care, critical care, infectious diseases, and pulmonology roles have experienced COVID-19 first hand—often risking their own health and that of their families to help. A new report from Apollo Intelligence provides a barometer on physicians’ sentiments for 2022, and together with other research, frames a wake-up call to medical device and pharma teams in charge of building a brand presence with prescribers.
Rare Patient Voice LLC, a leading patient recruitment firm, and MediFind, an advanced digital health platform helping people facing complex health challenges find better care, faster, published a report examining the current state of the diagnostic odyssey for patients with complex diseases during these times of global health issues.
The Biotechnology Innovation Organization (BIO) provides a glimpse of economic development in the biosciences ecosystem at the state and regional levels. The report, which was developed in partnership with the Council of State Bioscience Associations (CSBA), was released as an industry analysis in the wake of the COVID-19 pandemic and its impact on the overall economy.
Amid the turmoil of the recurring waves of the pandemic, pharma marketers are shifting their focus to new and innovative solutions to engage healthcare professionals (HCPs), which has led to acceleration of programmatic messaging technologies in the sector.
Massive layoffs could be headed to Biogen due to the disappointing rollout of the company’s Alzheimer’s drug Aduhelm that generated only a few million dollars in revenue over the past two quarters.
Fewer Americans are dying from the most common types of cancer, especially lung, showed a report published in The Journal of the National Cancer Institute on July 8.
Initially traced to about 100 cases of Covid-19 that spread across the United States, the number of infections linked to a Biogen corporate conference held in February 2020 at the Boston Marriott Long Wharf Hotel has grown exponentially and researchers estimate the total could be as many as 300,000.
UK regulators stated that they received two reports of potential allergic reactions linked to the Covid-19 vaccine from Pfizer and BioNTech, according to the Associated Press.
Biopharma Industry Donates More Money to Democrats, Reversing Trend of Higher Republican SupportBiopharma, Center for Responsive Politics, COVID-19 Vaccines, Democrats, Donald Trump, Emergency Use Authorization, FDA, Joe Biden, Political Donors, Prescription Drugs, Presidential Campaigns, Reports, Republicans, Research Groups
Drug companies’ political committees have largely donated to Republican presidential campaigns since 1990, but that trend has noticeably reversed come the 2020 election cycle, according to a new report from the Center for Responsive Politics.